Acu Doula BC
  • Home
  • Services
    • Acupressure
    • Reflexology
    • Manual Lymph Drainage
    • Massage
    • Doula
  • Contact
  • Blog

December 28th, 2016

12/28/2016

0 Comments

 
VITAMIN E INTAKE MAY BE LINKED TO INCREASED BONE DENSITY AND REDUCED FRACTURE RISKRecent studies have indicated that oxidative stress may be a contributing factor in the development of decreased bone density and an increased risk of bone fracture.
The study, published in the journal Osteoporosis International, included 21,774 Norwegian men and women aged 65-79 that were part of a community-based health study. Serum Vitamin E concentrations were measured at the beginning of the study and subjects were followed for 11 years.
During the course of the follow up, 1,168 hip fractures were reported in both men and women. After adjusting for smoking, month of blood sample, BMI, education, physical inactivity, self-rated health, and serum 25-hydroxy vitamin D (25(OH)D), serum vitamin E levels showed a linear inverse association with hip fracture risk. Among subjects in the lowest quartile (25%) of serum Vitamin E, the risk of hip fracture was 51% higher than those whose levels were among the top 25%.
In this population, low serum vitamin E concentrations were associated with an increased risk of hip fractures. These results confirm the findings of two recent cohort studies, which also found an increased risk of bone fracture among older adults with low serum vitamin E concentrations. The researchers suggest that in addition to its antioxidant effect, vitamin E could have a direct role in bone remodeling. However, further research is needed to clarify the role of vitamin E in maintaining bone health.
Holvik K, Gjesdal CG, Tell GS, et al. Low serum concentrations of alpha-tocopherol are associated with increased risk of hip fracture. A NOREPOS study. Osteoporos Int. 2014;25(11):2545-54.
Michaëlsson K, Wolk A, Byberg L, Ärnlöv J, Melhus H. Intake and serum concentrations of α-tocopherol in relation to fractures in elderly women and men: 2 cohort studies. Am J Clin Nutr. 2014;99(1):107-14.

0 Comments

December 07th, 2016

12/7/2016

0 Comments

 
COENZYME Q10 SUPPLEMENTATION AND MALE FERTILITY
Previous research has shown that Coenzyme Q10 is present in measurable levels in human seminal fluid, where it most likely exerts important metabolic and antioxidant functions.

In a paper published in Fertility and Sterility, researchers evaluated the effectiveness of CoQ10 treatment in improving semen quality in men with idiopathic infertility. Idiopathic infertility is defined as infertility without a defined or known cause.

The placebo-controlled, double-blind randomized trial included 60 male infertility patients aged 27-39 years. The participants took either 200 mg/day of CoQ10 (ubiquinone) or a placebo for 6 months, with 3 months of follow-up.

Coenzyme Q10 and ubiquinol increased significantly in both seminal plasma and sperm cells after treatment, as well as increasing sperm motility. Patients with lower baseline values of sperm motility and CoQ10 levels had a greater likelihood of responding positively to the treatment.

Coenzyme Q10 supplementation increases the level of ubiquinone and ubiquinol in semen and is effective in improving sperm motility in patients affected by unexplained infertility.

Balercia G, Buldreghini E, Vignini A, et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril. 2009;91(5):1785-92.
0 Comments

December 07th, 2016

12/7/2016

0 Comments

 
FISH OIL MAY REDUCE MUSCLE LOSS FROM CHEMOTHERAPY TREATMENTUnintended weight loss is a major cause of increased mortality and health problems in patients with advanced cancer. Muscle and weight loss caused by chemotherapy can greatly reduce quality of life and prevent patients from receiving further treatments.
Research published in the American Cancer Society journal Cancer shows a protective effect for fish oil against the loss of muscle tissue and weight that occurs during chemotherapy treatment.
Researchers conducted a clinical trial of lung cancer patients receiving their initial chemotherapy treatments. Forty patients completed the study; 16 were in the fish oil group (dose of 2.2 g of EPA/day) while 24 other patients received standard care (no fish oil). Skeletal muscle and adipose tissue were measured using computed tomography images at baseline and the end of treatment. Weight was measured and blood samples were analyzed at the beginning and throughout treatment. Average treatment time was 10 weeks.
While the group that received standard care (no fish oil) lost an average of 5 lbs, patients that received fish oil maintained their weight. Nearly 70% of those who supplemented with fish oil gained or maintained muscle, compared to only 29 percent of those who did not receive it. Patients whose EPA (from fish oil) levels increased the most had the most significant muscle gains. Those who did not receive fish oil lost an average of 2.2 lbs of muscle. Fat mass did not differ between groups.
Larger studies need to be done to verify these findings, but they are significant since currently there are no effective treatments for cancer-related malnutrition.
Note: Always consult with your doctor about supplementation if you are undergoing treatment. But, this is an interesting study that may be worth discussing with your health professional.
Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer. 2011;117(8):1775-82.

0 Comments

    Archives

    April 2020
    February 2017
    December 2016
    August 2016
    July 2016
    March 2016
    February 2016
    January 2016
    August 2015
    June 2015
    March 2015
    February 2015
    January 2015

    Categories

    All

    RSS Feed

Powered by Create your own unique website with customizable templates.